Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 14 | 2020 | 1204 | 2.100 |
Why?
|
| Fibroblasts | 13 | 2020 | 902 | 1.960 |
Why?
|
| Extracellular Matrix | 10 | 2020 | 493 | 1.530 |
Why?
|
| Heart | 7 | 2022 | 850 | 1.280 |
Why?
|
| Fibrosis | 5 | 2014 | 371 | 1.250 |
Why?
|
| Collagen | 7 | 2013 | 636 | 1.010 |
Why?
|
| Gold | 6 | 2014 | 76 | 0.980 |
Why?
|
| Collagen Type I | 4 | 2014 | 175 | 0.870 |
Why?
|
| Myofibroblasts | 2 | 2014 | 60 | 0.850 |
Why?
|
| Receptors, Mitogen | 4 | 2014 | 23 | 0.790 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2014 | 100 | 0.760 |
Why?
|
| Receptors, Collagen | 2 | 2011 | 9 | 0.750 |
Why?
|
| Ventricular Remodeling | 6 | 2022 | 318 | 0.680 |
Why?
|
| Nanotubes | 3 | 2014 | 22 | 0.560 |
Why?
|
| Rats | 14 | 2014 | 5300 | 0.520 |
Why?
|
| Animals | 23 | 2022 | 20881 | 0.460 |
Why?
|
| Cell Degranulation | 1 | 2012 | 24 | 0.430 |
Why?
|
| Organ Specificity | 1 | 2013 | 167 | 0.430 |
Why?
|
| Fibrillar Collagens | 1 | 2012 | 49 | 0.420 |
Why?
|
| Mast Cells | 1 | 2012 | 113 | 0.410 |
Why?
|
| Metal Nanoparticles | 2 | 2008 | 88 | 0.370 |
Why?
|
| Diabetes Complications | 1 | 2012 | 249 | 0.350 |
Why?
|
| Organogenesis | 1 | 2010 | 49 | 0.350 |
Why?
|
| Adaptation, Physiological | 2 | 2008 | 189 | 0.330 |
Why?
|
| Discoidin Domain Receptors | 4 | 2014 | 16 | 0.330 |
Why?
|
| Mesoderm | 1 | 2010 | 231 | 0.330 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 54 | 0.330 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 498 | 0.330 |
Why?
|
| Signal Transduction | 3 | 2018 | 2689 | 0.310 |
Why?
|
| Cell Shape | 1 | 2008 | 37 | 0.310 |
Why?
|
| Stress, Mechanical | 3 | 2013 | 208 | 0.310 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 236 | 0.300 |
Why?
|
| Biomechanical Phenomena | 4 | 2013 | 368 | 0.290 |
Why?
|
| Electrophoresis, Capillary | 1 | 2006 | 15 | 0.280 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 112 | 0.270 |
Why?
|
| Animals, Newborn | 4 | 2011 | 396 | 0.270 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 694 | 0.260 |
Why?
|
| Cells, Cultured | 5 | 2020 | 2673 | 0.250 |
Why?
|
| Integrins | 3 | 2014 | 115 | 0.240 |
Why?
|
| Gene Expression | 1 | 2006 | 770 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1085 | 0.230 |
Why?
|
| Integrin beta Chains | 1 | 2002 | 7 | 0.220 |
Why?
|
| Integrin beta1 | 1 | 2003 | 48 | 0.220 |
Why?
|
| Cachexia | 2 | 2020 | 54 | 0.210 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2022 | 85 | 0.200 |
Why?
|
| Cell Movement | 4 | 2013 | 630 | 0.190 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 248 | 0.190 |
Why?
|
| Cell Proliferation | 4 | 2013 | 1174 | 0.190 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1034 | 0.190 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2020 | 140 | 0.190 |
Why?
|
| Microscopy, Confocal | 4 | 2005 | 337 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 89 | 0.170 |
Why?
|
| Cell Communication | 2 | 2010 | 116 | 0.160 |
Why?
|
| Cell Survival | 2 | 2012 | 901 | 0.160 |
Why?
|
| Nanoparticles | 2 | 2014 | 254 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 277 | 0.150 |
Why?
|
| Muscle Proteins | 1 | 2018 | 94 | 0.150 |
Why?
|
| Cell Adhesion | 2 | 2013 | 324 | 0.150 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 181 | 0.150 |
Why?
|
| Phenotype | 3 | 2020 | 947 | 0.150 |
Why?
|
| Muscle Contraction | 1 | 2018 | 210 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 481 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2018 | 330 | 0.140 |
Why?
|
| Mice | 6 | 2022 | 8474 | 0.130 |
Why?
|
| Heart Failure | 2 | 2020 | 1180 | 0.130 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 27 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 58 | 0.110 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2012 | 10 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 170 | 0.110 |
Why?
|
| Tensile Strength | 1 | 2012 | 90 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2013 | 45 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2550 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2012 | 152 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 146 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2013 | 109 | 0.100 |
Why?
|
| Stroke Volume | 3 | 2022 | 586 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 492 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 1293 | 0.100 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 122 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 247 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 223 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 2791 | 0.090 |
Why?
|
| Endocardial Cushions | 1 | 2010 | 20 | 0.090 |
Why?
|
| Myocardial Contraction | 2 | 2010 | 383 | 0.090 |
Why?
|
| Proteins | 1 | 2014 | 474 | 0.090 |
Why?
|
| Endocardium | 1 | 2010 | 101 | 0.090 |
Why?
|
| Peptides | 1 | 2012 | 455 | 0.090 |
Why?
|
| Microscopy, Electron | 3 | 2004 | 351 | 0.080 |
Why?
|
| Chick Embryo | 1 | 2010 | 379 | 0.080 |
Why?
|
| Humans | 8 | 2014 | 68618 | 0.080 |
Why?
|
| Dimerization | 1 | 2009 | 99 | 0.080 |
Why?
|
| Heart Atria | 1 | 2010 | 206 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1667 | 0.080 |
Why?
|
| Cell Line | 1 | 2012 | 1752 | 0.080 |
Why?
|
| Gels | 1 | 2008 | 55 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 167 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 328 | 0.080 |
Why?
|
| Materials Testing | 1 | 2009 | 263 | 0.080 |
Why?
|
| Muscle, Smooth | 1 | 2008 | 117 | 0.080 |
Why?
|
| Drug Carriers | 1 | 2008 | 90 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 807 | 0.080 |
Why?
|
| Nanostructures | 1 | 2008 | 112 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 249 | 0.070 |
Why?
|
| Molecular Probes | 1 | 2007 | 27 | 0.070 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2006 | 4 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 384 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 95 | 0.070 |
Why?
|
| Lasers | 1 | 2006 | 61 | 0.070 |
Why?
|
| Protein Binding | 1 | 2009 | 1027 | 0.070 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2020 | 396 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2010 | 738 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 911 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 689 | 0.060 |
Why?
|
| Base Sequence | 1 | 2006 | 1015 | 0.060 |
Why?
|
| Time Factors | 3 | 2013 | 4655 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2004 | 25 | 0.060 |
Why?
|
| Connexins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 236 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2004 | 62 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 322 | 0.060 |
Why?
|
| Male | 5 | 2020 | 37321 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 45 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 144 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2003 | 37 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 76 | 0.050 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2003 | 59 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.050 |
Why?
|
| Muscle Cells | 2 | 2018 | 30 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 132 | 0.050 |
Why?
|
| Cytological Techniques | 1 | 2002 | 23 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2022 | 67 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1664 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 954 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 144 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 507 | 0.050 |
Why?
|
| Scattering, Radiation | 2 | 2013 | 30 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 2083 | 0.050 |
Why?
|
| Hypertension | 1 | 2010 | 1535 | 0.050 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 161 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2002 | 442 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1692 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2018 | 20 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 32 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 596 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1033 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 2334 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2020 | 718 | 0.030 |
Why?
|
| Apoptosis | 1 | 2002 | 1641 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1864 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2014 | 20 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 47 | 0.030 |
Why?
|
| Polyethylenes | 1 | 2014 | 31 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 272 | 0.030 |
Why?
|
| Cetrimonium Compounds | 1 | 2013 | 4 | 0.030 |
Why?
|
| Adsorption | 1 | 2014 | 225 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 149 | 0.030 |
Why?
|
| Cattle | 1 | 2014 | 475 | 0.030 |
Why?
|
| Surface Properties | 1 | 2014 | 363 | 0.030 |
Why?
|
| Nitrogen | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2013 | 103 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 189 | 0.030 |
Why?
|
| Light | 1 | 2013 | 152 | 0.030 |
Why?
|
| Female | 3 | 2022 | 38074 | 0.020 |
Why?
|
| Software | 1 | 2013 | 418 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 97 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 252 | 0.020 |
Why?
|
| Microscopy | 1 | 2007 | 64 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 1038 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 1851 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 25 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2003 | 32 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2003 | 17 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 20 | 0.010 |
Why?
|
| Myofibrils | 1 | 2003 | 35 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2002 | 16 | 0.010 |
Why?
|
| Resins, Synthetic | 1 | 2002 | 7 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 85 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 160 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2002 | 144 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2002 | 66 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 194 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 233 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1174 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 643 | 0.010 |
Why?
|